首页> 美国卫生研究院文献>Journal of Virology >High-level expression of the tick-borne encephalitis virus NS1 protein by using an adenovirus-based vector: protection elicited in a murine model.
【2h】

High-level expression of the tick-borne encephalitis virus NS1 protein by using an adenovirus-based vector: protection elicited in a murine model.

机译:使用基于腺病毒的载体高表达protein传性脑炎病毒NS1蛋白:在鼠模型中引起保护。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Tick-borne encephalitis virus (TBEV) encodes an abundant, highly immunogenic nonstructural glycoprotein, NS1. The function of this protein has yet to be determined. We have cloned the NS1 gene from the Neudorfl strain of TBEV under the control of the powerful constitutive cytomegalovirus major immediate-early promoter into an adenovirus E1 deletion mutant. The novel combination of the cytomegalovirus immediate-early promoter and the adenovirus vector produced extremely high levels of NS1 expression in cells which do not support replication of the adenovirus deletion mutant. The recombinant protein was shown to be indistinguishable from authentic TBEV NS1 in its (i) apparent molecular weight by polyacrylamide gel electrophoresis, (ii) glycosylation pattern, (iii) ability to form high-molecular-weight complexes, and (iv) ability to be secreted from cells. Appropriate processing of NS1 expressed by the adenovirus recombinant occurred independently of any additional TBEV-encoded gene function. When directly inoculated into mice, the recombinant adenovirus RAd51 was shown to elicit an antibody response to the TBEV NS1 protein. Immunization with RAd51 conferred protection against challenge with TBEV.
机译:ick传脑炎病毒(TBEV)编码丰富的,高度免疫原性的非结构性糖蛋白NS1。该蛋白的功能尚未确定。我们已经在强大的组成型巨细胞病毒主要立即早期启动子的控制下,从TBEV的Neudorfl菌株中克隆了NS1基因到腺病毒E1缺失突变体中。巨细胞病毒立即早期启动子和腺病毒载体的新颖组合在不支持腺病毒缺失突变体复制的细胞中产生了极高水平的NS1表达。重组蛋白在以下方面显示出与正宗TBEV NS1的区别:(i)通过聚丙烯酰胺凝胶电泳的表观分子量,(ii)糖基化模式,(iii)形成高分子量复合物的能力和(iv)从细胞中分泌出来。由腺病毒重组体表达的NS1的适当加工独立于任何其他TBEV编码的基因功能而发生。当直接接种到小鼠中时,重组腺病毒RAd51被证明引发针对TBEV NS1蛋白的抗体反应。接种RAd51可以防止TBEV感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号